price

NASDAQ · LXRX
Lexicon Pharmaceuticals, Inc.
Healthcare · Biotechnology
$1.79
Down-$0.03 (-1.65%)
Updated Nov 14, 2026, 2:20 PM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 481.5M
- P/E ratio
- -3.99
- Dividend yield
- 0.00%
- 52-week range
- $1.37 – $2.68
- Volume
- 1.89M
- Avg. volume
- 2.31M
Price performance · LXRX
LXRX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
LXRX closed at $1.79 after 21 trading sessions, up 17.76% for the selected period.
- Last close
- $1.79
- Period change
- +17.76%
- Period low
- $1.42
- Period high
- $1.87
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $1.83 | $1.83 | $1.72 | $1.79 | 1.89M |
| Nov 12, 2026 | $1.87 | $1.89 | $1.78 | $1.82 | 1.69M |
| Nov 11, 2026 | $1.87 | $1.92 | $1.85 | $1.87 | 3.09M |
| Nov 10, 2026 | $1.80 | $1.9695 | $1.80 | $1.86 | 3.41M |
| Nov 9, 2026 | $1.88 | $1.9178 | $1.79 | $1.82 | 2.56M |
| Nov 6, 2026 | $1.66 | $1.84 | $1.61 | $1.78 | 3.6M |
| Nov 5, 2026 | $1.57 | $1.6399 | $1.51 | $1.61 | 3.8M |
| Nov 4, 2026 | $1.50 | $1.54 | $1.46 | $1.48 | 1.95M |
| Nov 3, 2026 | $1.44 | $1.515 | $1.44 | $1.46 | 1.04M |
| Nov 2, 2026 | $1.44 | $1.45 | $1.40 | $1.44 | 2.02M |
| Oct 30, 2026 | $1.47 | $1.4961 | $1.375 | $1.42 | 2.44M |
| Oct 29, 2026 | $1.50 | $1.52 | $1.43 | $1.48 | 1.77M |
| Oct 28, 2026 | $1.47 | $1.49 | $1.43 | $1.485 | 1.62M |
| Oct 27, 2026 | $1.47 | $1.49 | $1.435 | $1.48 | 1.86M |
| Oct 26, 2026 | $1.40 | $1.48 | $1.40 | $1.45 | 2.21M |
| Oct 23, 2026 | $1.50 | $1.50 | $1.365 | $1.42 | 2.68M |
| Oct 22, 2026 | $1.56 | $1.59 | $1.48 | $1.49 | 1.32M |
| Oct 21, 2026 | $1.59 | $1.6171 | $1.545 | $1.56 | 1.4M |
| Oct 20, 2026 | $1.56 | $1.63 | $1.545 | $1.58 | 1.41M |
| Oct 19, 2026 | $1.55 | $1.5799 | $1.5102 | $1.55 | 1.72M |
| Oct 16, 2026 | $1.68 | $1.68 | $1.52 | $1.52 | 2.01M |
Latest LXRX news
The latest Smart Investors Daily articles mentioning LXRX.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

